Related Experiment Video
Updated: Aug 12, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
A diabetes control program in a public health care setting
S B Baker1, C Vallbona, V Pavlik
1Department of Community Medicine, Baylor College of Medicine, Houston, TX 77030.
Public Health Reports (Washington, D.C. : 1974)
|September 1, 1993
Summary
The Houston Diabetes Control Program improved eye and foot care for high-risk patients. While beneficial for preventing blindness and foot issues, challenges remain in blood sugar and weight management.
Area of Science:
- Public Health
- Endocrinology
- Preventive Medicine
Background:
- The Houston Diabetes Control Program addresses diabetes complications in an urban, high-risk population.
- The program targets cultural, ethnic, and economic challenges faced by patients.
- It focuses on state-of-the-art preventive care and treatment for diabetes-related issues.
Purpose of the Study:
- To implement and evaluate protocols for preventing and managing diabetes complications.
- To improve eye, lower extremity, and cardiovascular care for diabetic patients.
- To enhance patient and professional education regarding diabetes management.
Main Methods:
- Development and implementation of care protocols across nine community health centers.
- Focus on preventive care for eye, lower extremity, and cardiovascular complications.
- Patient and professional education initiatives integrated into the program.
Main Results:
- Increased eye examinations from 8% to 26%; reduced legal blindness incidence.
- Increased foot examinations from 18% to 44%.
- Achieved good blood pressure control ( < 160/95 mmHg) in 77% of hypertensive patients; no significant long-term improvements in weight or blood glucose control.
Conclusions:
- The program shows success in improving specific preventive care metrics like eye and foot exams and reducing blindness.
- Significant challenges persist in glycemic control, hypertension, and cholesterol management.
- Future efforts require enhanced diet, physical activity, and educational interventions, alongside professional collaboration.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
